![PDF) Quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma: The TOURMALINE-MM3 trial PDF) Quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma: The TOURMALINE-MM3 trial](https://i1.rgstatic.net/publication/338189171_Quality_of_life_is_maintained_with_ixazomib_maintenance_in_post-transplant_newly_diagnosed_multiple_myeloma_The_TOURMALINE-MM3_trial/links/5e98fd91299bf13079a1d56b/largepreview.png)
PDF) Quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma: The TOURMALINE-MM3 trial
![Frontiers | Salidroside Inhibits Myogenesis by Modulating p-Smad3-Induced Myf5 Transcription | Pharmacology Frontiers | Salidroside Inhibits Myogenesis by Modulating p-Smad3-Induced Myf5 Transcription | Pharmacology](https://www.frontiersin.org/files/Articles/337325/fphar-09-00209-HTML-r1/image_m/fphar-09-00209-g002.jpg)
Frontiers | Salidroside Inhibits Myogenesis by Modulating p-Smad3-Induced Myf5 Transcription | Pharmacology
![PDF) Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139] PDF) Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139]](https://i1.rgstatic.net/publication/7409869_Impact_of_efalizumab_on_patient-reported_outcomes_in_high-need_psoriasis_patients_results_of_the_international_randomized_placebo-controlled_Phase_III_Clinical_Experience_Acquired_with_Raptiva_CLEAR_t/links/0f5a3dc238298438a2f77598/largepreview.png)
PDF) Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139]
![PDF) Inhibiting the two-component system GraXRS with verteporfin to combat Staphylococcus aureus infections PDF) Inhibiting the two-component system GraXRS with verteporfin to combat Staphylococcus aureus infections](https://i1.rgstatic.net/publication/345158984_Inhibiting_the_two-component_system_GraXRS_with_verteporfin_to_combat_Staphylococcus_aureus_infections/links/5fb6bac292851c933f3f462a/largepreview.png)
PDF) Inhibiting the two-component system GraXRS with verteporfin to combat Staphylococcus aureus infections
![PDF) NEMA NU 2012 Performance Evaluation of Silicon-Photomultiplier– Based and conventional PMT-based Time-of-Flight systems PDF) NEMA NU 2012 Performance Evaluation of Silicon-Photomultiplier– Based and conventional PMT-based Time-of-Flight systems](https://i1.rgstatic.net/publication/344366720_NEMA_NU_2012_Performance_Evaluation_of_Silicon-Photomultiplier-_Based_and_conventional_PMT-based_Time-of-Flight_systems/links/5f6cd60e458515b7cf4c3e15/largepreview.png)
PDF) NEMA NU 2012 Performance Evaluation of Silicon-Photomultiplier– Based and conventional PMT-based Time-of-Flight systems
![PDF) From transplant to novel cellular therapies in multiple myeloma: EMN guidelines and future perspectives PDF) From transplant to novel cellular therapies in multiple myeloma: EMN guidelines and future perspectives](https://i1.rgstatic.net/publication/321672076_From_transplant_to_novel_cellular_therapies_in_multiple_myeloma_EMN_guidelines_and_future_perspectives/links/5a84d5b04585159152b80d2c/largepreview.png)
PDF) From transplant to novel cellular therapies in multiple myeloma: EMN guidelines and future perspectives
![PDF) Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial PDF) Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial](https://i1.rgstatic.net/publication/335240369_Efficacy_of_TIMOLOL_nasal_spray_as_a_treatment_for_epistaxis_in_hereditary_hemorrhagic_telangiectasia_A_double-blind_randomized_placebo-controlled_trial/links/5d5a988d299bf1b97cf5496d/largepreview.png)
PDF) Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial
![PDF) The Nac2 gene of Chlamydomonas encodes a chloroplast TPR-like protein involved in psbD mRNA stability PDF) The Nac2 gene of Chlamydomonas encodes a chloroplast TPR-like protein involved in psbD mRNA stability](https://i1.rgstatic.net/publication/12439424_The_Nac2_gene_of_Chlamydomonas_encodes_a_chloroplast_TPR-like_protein_involved_in_psbD_mRNA_stability/links/09e4150853eeba89b3000000/largepreview.png)